[go: up one dir, main page]

TN2010000469A1 - 2-9 diamino pyrimidin 5 yl carboxamides as syk or jak kinases inhibitors - Google Patents

2-9 diamino pyrimidin 5 yl carboxamides as syk or jak kinases inhibitors

Info

Publication number
TN2010000469A1
TN2010000469A1 TNP2010000469A TN2010000469A TN2010000469A1 TN 2010000469 A1 TN2010000469 A1 TN 2010000469A1 TN P2010000469 A TNP2010000469 A TN P2010000469A TN 2010000469 A TN2010000469 A TN 2010000469A TN 2010000469 A1 TN2010000469 A1 TN 2010000469A1
Authority
TN
Tunisia
Prior art keywords
syk
methods
jak kinase
carboxamides
jak kinases
Prior art date
Application number
TNP2010000469A
Other languages
French (fr)
Inventor
Shawn M Bauer
Zhaozhong J Jia
Yonghong Song
Qing Xu
Mukund Mehrotra
Jack W Rose
Wolin Huang
Chandrasekar Venkataramani
Anjali Pandey
Original Assignee
Portola Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/002420 external-priority patent/WO2009145856A1/en
Application filed by Portola Pharm Inc filed Critical Portola Pharm Inc
Publication of TN2010000469A1 publication Critical patent/TN2010000469A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention is directed to compounds of formula I-II and pharmaceutically acceptable tautomers, salts, or stereoisomers thereof which are inhibitors of syk and/or JAK kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk and/or JAK kinase activity, methods of inhibition the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk and/or JAK kinase activity, such as cardiovascular disease, inflammatory disease, autoimmune disease and cell proliferative disorder, thrombosis, allergy, asthma, rheumatoid arthritis, leukemia, or non-Hodgkin's lymphoma.
TNP2010000469A 2009-04-16 2010-10-14 2-9 diamino pyrimidin 5 yl carboxamides as syk or jak kinases inhibitors TN2010000469A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/002420 WO2009145856A1 (en) 2008-04-16 2009-04-16 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors

Publications (1)

Publication Number Publication Date
TN2010000469A1 true TN2010000469A1 (en) 2012-05-24

Family

ID=55024580

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000469A TN2010000469A1 (en) 2009-04-16 2010-10-14 2-9 diamino pyrimidin 5 yl carboxamides as syk or jak kinases inhibitors

Country Status (1)

Country Link
TN (1) TN2010000469A1 (en)

Similar Documents

Publication Publication Date Title
MY155639A (en) 2, 6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinases inhibitors
MX2010011464A (en) 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors.
NZ589315A (en) 2,6-diamino-pyrimidin-5-yl-carboxamides as Spleen tryosine kinase (syk) or Janus kinase (JAK) inhibitors
PH12013502445A1 (en) Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
MY156727A (en) N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
MD4735B1 (en) Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of Janus-related Kinases (JAK)
MX366629B (en) Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions.
NZ588830A (en) Inhibitors of protein kinases
PH12014500103A1 (en) Pyridin-2(1h)-one derivatives as jak inhibitors
WO2009136995A3 (en) 2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
PH12012502334A1 (en) Heteroaryl imidazolone derivatives as jak inhibitors
AU2012258977A8 (en) Inhibitors of LRRK2 kinase activity
MX2012009074A (en) Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors.
GEP20156285B (en) Compounds and compositions as trk inhibitors
SG195106A1 (en) Trpv4 antagonists
WO2012054364A3 (en) Bicyclic diamines as janus kinase inhibitors
JO3398B1 (en) 2,3-Dihydro-benzo[1,4]oxazine derivatives and related compounds as phosphoinositide-3 kinase (PI3K) inhibitors for the treatment of e.g. rheumatoid arthritis
PH12012501164A1 (en) Imidazopyridine derivatives as jak inhibitors
PH12014500730A1 (en) 5,7-substituted-imidazo[1,2-c]pyrimidines
SG10201805392YA (en) 1,2,4-triazine-6-carboxamide kinase inhibitors
MX2013008296A (en) Diarylacetylene hydrazide containing tyrosine kinase inhibitors.
TN2011000404A1 (en) Fused pyrimidines
MX363551B (en) Pyrazine kinase inhibitors.
MX336332B (en) Kinase inhibitors, prodrug forms thereof and their use in therapy.
MX341577B (en) Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mtor inhibitors.